Opinion
2026’s abortion battles will be fought more in courthouses and FDA offices | The Conversation
Texas won its case in a Texas court and then asked New York to enforce the judgment of more than $100,000 in fines and fees. A New York court has refused to do so, citing its shield law. New York also ...
Hawley and other anti-abortion groups and legislators say the health organization is "slow-walking" a review of the drug mifepristone.
The Texas Tribune on MSN
Texas, Florida sue FDA over abortion pill approval
Seeking to pull mifepristone from the drug market, the states argued that the FDA did not properly evaluate the pill’s safety ...
Richard Pazdur, a top regulator at the Food and Drug Administration, is resigning. Pazdur has filed papers to leave at the end of this month. (STAT News) In a case centered around abortion, the ...
The FDA is reviewing the supplemental BLA for lisocabtagene maraleucel (liso-cel), a CD19-directed genetically modified autologous T cell immunotherapy, for relapsed or refractory (R/R) marginal zone ...
An anti-vaccine group with ties to Health Secretary Robert F. Kennedy Jr. sued New York on Monday over its 2019 law ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results